Mesoblast (MESO) Prepaid Assets (2015 - 2026)
Mesoblast (MESO) posted Prepaid Assets of $7.5 million for Q4 2025, up 32.65% sequentially from $5.7 million in Q2 2025, and up 69.15% YoY from $4.5 million in Q4 2024.
Analysis
Mesoblast (MESO) Prepaid Assets (2015 - 2026) Analysis & Trends
Mesoblast has reported Prepaid Assets for 11 years, with the latest figure at $7.5 million in Q4 2025.
- Quarterly Prepaid Assets rose 69.15% year-over-year to $7.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.5 million (up 69.15% YoY) and the FY2025 annual result came in at $5.7 million, up 122.93% from the prior year.
- Prepaid Assets grew to $7.5 million in Q4 2025 per MESO's latest filing, from $5.7 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $8.6 million in Q1 2021 and troughed at $2.6 million in Q2 2024.
- A 5-year average of $5.2 million and a median of $5.0 million in 2022 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets slumped 33.28% in 2023, then jumped 122.93% in 2025.
- Over 5 years, Prepaid Assets stood at $7.9 million in 2021, then plunged by 31.66% to $5.4 million in 2022, then plunged by 33.28% to $3.6 million in 2023, then advanced by 23.82% to $4.5 million in 2024, then soared by 69.15% to $7.5 million in 2025.
- According to Business Quant data, Prepaid Assets over the past three periods registered $7.5 million, $5.7 million, and $4.5 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Mesoblast | 2.24 Bn | 2.14 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.81 Mn |
| Dec 31, 2025 | 7.54 Mn |
| Jun 30, 2025 | 5.69 Mn |
| Dec 31, 2024 | 4.46 Mn |
| Jun 30, 2024 | 2.55 Mn |
| Dec 31, 2023 | 3.60 Mn |
| Jun 30, 2023 | 3.34 Mn |
| Mar 31, 2023 | 4.17 Mn |
| Dec 31, 2022 | 5.40 Mn |
| Sep 30, 2022 | 3.60 Mn |
| Jun 30, 2022 | 4.99 Mn |
| Mar 31, 2022 | 5.74 Mn |
| Dec 31, 2021 | 7.90 Mn |
| Sep 30, 2021 | 4.64 Mn |
| Jun 30, 2021 | 6.50 Mn |
| Mar 31, 2021 | 8.56 Mn |
| Dec 31, 2020 | 9.59 Mn |
| Sep 30, 2020 | 5.17 Mn |
| Jun 30, 2020 | 5.65 Mn |
| Mar 31, 2020 | 6.32 Mn |